Diatech files IND for infection agent
Peptide-based imaging agent developer Diatech of Londonderry, NH, has filed an investigationalnew drug (IND) application with the Food and Drug Administrationfor a new radiopharmaceutical that detects infections of unknownorigin. The agent, Tc-99m P483H,
Peptide-based imaging agent developer Diatech of Londonderry, NH, has filed an investigationalnew drug (IND) application with the Food and Drug Administrationfor a new radiopharmaceutical that detects infections of unknownorigin. The agent, Tc-99m P483H, is a technetium-99m-labeled syntheticpeptide designed to home in on infection sites where white bloodcells are elevated as the body fights infection.